Status:
COMPLETED
Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary Syndrome
Lead Sponsor:
Catholic University of the Sacred Heart
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
The aim of this study is to compare the effects of six months treatment of two insulin-lowering therapies on the clinical and endocrine-metabolic parameters in obese women affected by polycystic ovary...
Eligibility Criteria
Inclusion
- women with Polycystic Ovary Syndrome, diagnosed in accordance with Rotterdam Consensus Conference Criteria 2003;
- BMI\>25 kg/m2;
- age 18-35 years.
Exclusion
- pregnancy;
- significant liver or renal impairment;
- other hormonal dysfunction (hypothalamic, pituitary, thyroidal or adrenal causes for the clinical signs);
- neoplasms;
- unstable mental illness;
- diagnosis of diabetes mellitus or impaired glucose tolerance;
- use of drugs able to interfere with gluco-insulinaemic metabolism for at least three months prior to entering the study.
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01791647
Start Date
June 1 2011
End Date
December 1 2012
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Sacred Heart
Rome, Italy, 00168